| Title |
Authors |
PubMed ID |
| 1 |
Longitudinal relationships among cerebrospinal fluid biomarkers, cerebral blood flow, and grey matter volume in individuals with a familial history of Alzheimer s disease |
Sanami S; Intzandt B; Huck J; Villeneuve S; Iturria-Medina Y; Gauthier CJ; Prevent-Ad Research Group None; |
40347524
CONCORDIA |
| 2 |
Sleep spindles and slow oscillations predict cognition and biomarkers of neurodegeneration in mild to moderate Alzheimer's disease |
Páez A; Gillman SO; Dogaheh SB; Carnes A; Dakterzada F; Barbé F; Dang-Vu TT; Ripoll GP; |
39878233
CONCORDIA |
| 3 |
The MyLo CRISPR-Cas9 Toolkit: A Markerless Yeast Localization and Overexpression CRISPR-Cas9 Toolkit |
Bean BDM; Whiteway M; Martin VJJ; |
35708612
BIOLOGY |
| 4 |
Amyloid-β (1-42) peptide induces rapid NMDA receptor-dependent alterations at glutamatergic synapses in the entorhinal cortex |
Olajide OJ; Chapman CA; |
34144329
PSYCHOLOGY |
| 5 |
Molecular mechanisms of neurodegeneration in the entorhinal cortex that underlie its selective vulnerability during the pathogenesis of Alzheimer's disease. |
Olajide OJ, Suvanto ME, Chapman CA |
33495355
PSYCHOLOGY |
| 6 |
Topographical distribution of Aβ predicts progression to dementia in Aβ positive mild cognitive impairment |
Pascoal TA, Therriault J, Mathotaarachchi S, Kang MS, Shin M, Benedet AL, Chamoun M, Tissot C, Lussier F, Mohaddes S, Soucy JP, Massarweh G, Gauthier S, Rosa-Neto P, |
32582834
PERFORM |
| 7 |
Flavanone glycosides inhibit β-site amyloid precursor protein cleaving enzyme 1 and cholinesterase and reduce Aβ aggregation in the amyloidogenic pathway. |
Ali MY, Jannat S, Edraki N, Das S, Chang WK, Kim HC, Park SK, Chang MS |
31194956
BIOLOGY |
| 8 |
Amyloid and tau signatures of brain metabolic decline in preclinical Alzheimer's disease. |
Pascoal TA, Mathotaarachchi S, Shin M, Park AY, Mohades S, Benedet AL, Kang MS, Massarweh G, Soucy JP, Gauthier S, Rosa-Neto P, Alzheimer’s Disease Neuroimaging Initiative |
29396637
PERFORM |
